Microbix Biosystms (MBX) Price & Analysis

Compare

34 Followers

MBX Stock Chart & Stats

Day’s Range― - ―

52-Week RangeC$0.28 - C$0.55

Previous CloseN/A

Volume37.35K

Average Volume (3M)82.41K

Market Cap

C$39.91M

Enterprise ValueC$50.57M

Total Cash (Recent Filing)C$14.54M

Total Debt (Recent Filing)C$5.35M

Price to Earnings (P/E)24.6

Beta-0.25

Next Earnings

Aug 14, 2025

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.00

Shares Outstanding140,025,390

10 Day Avg. Volume136,177

30 Day Avg. Volume82,408

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

C$0.50

Price Target Upside78.57% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering2

Bulls Say, Bears Say

Bulls Say

Antigen RevenuesAntigen revenues beat this quarter increasing 5% year over year to $4.3 million.

Financial PerformanceMicrobix reported FY1Q-2025 financials beating Bloom Burton’s estimates.

Product ExpansionWith increased adoption in emerging markets and expansion into recombinant antigens, continued robust growth of this product line is expected.

Bears Say

Chinese MarketSales of antigens for Chinese customers have abruptly stopped, impacting a significant portion of the company's revenue.

Respiratory Disease DemandThe unusually light burden of respiratory infectious diseases in China has decreased the demand for Microbix's antigen shipments.

Revenue DeclineTotal revenues declined 28% Y/Y.

Microbix Biosystms News

Microbix Biosystems to Announce Q3 Fiscal 2025 Results

Microbix Biosystms ( ($TSE:MBX) ) has provided an announcement. Microbix Biosystems Inc. announced the upcoming release of its...

6d ago

Microbix Biosystems Expands Diagnostic Support with QUANTDx Launch

An announcement from Microbix Biosystms ( ($TSE:MBX) ) is now available. Microbix Biosystems Inc. has launched QUANTDx™, a...

15d ago

Microbix Biosystems Showcases Pandemic Preparedness at ADLM Conference

Microbix Biosystms ( ($TSE:MBX) ) has shared an announcement. Microbix Biosystems Inc. announced its participation in the Association...

20d ago

Microbix Partners with Bulgaria’s NCIPD to Enhance Diagnostic Test Accuracy

The latest update is out from Microbix Biosystms ( ($TSE:MBX) ). Microbix Biosystems Inc. has entered into a...

1M ago

Microbix Showcases Diagnostic Innovations at Asia Pacific Conference

Microbix Biosystms ( ($TSE:MBX) ) has issued an announcement. Microbix Biosystems Inc. announced its participation in the Asia...

2M ago

Buy Rating for Microbix Biosystems: Strong Antigen Revenue Growth and Mid-Term Market Potential

Analyst David Martin PhD of Bloom Burton maintained a Buy rating on Microbix Biosystms (MBX – Research Report),...

3M ago

Microbix Biosystems’ Earnings Call Highlights Growth Amid Challenges

Microbix Biosystms (($TSE:MBX)) has held its Q2 earnings call. Read on for the main highlights of the call....

3M ago

MBX

Microbix Biosystems Reports Q2 Fiscal 2025 Results with Improved Margins and Cautious Outlook

Microbix Biosystms ( ($TSE:MBX) ) has shared an announcement. Microbix Biosystems reported its Q2 fiscal 2025 results, showing...

3M ago

Microbix and Aurevia Launch Pilot EQA Program for Bacterial Vaginosis Diagnosis

Microbix Biosystms ( ($TSE:MBX) ) just unveiled an announcement. Microbix Biosystems Inc., in collaboration with Aurevia Oy, has...

3M ago

Microbix Biosystems to Release Q2 Fiscal 2025 Results

Microbix Biosystms ( ($TSE:MBX) ) just unveiled an update. Microbix Biosystems Inc. has announced the release of its...

3M ago

MBX FAQ

What was Microbix Biosystms J’s price range in the past 12 months?

Microbix Biosystms J lowest stock price was C$0.28 and its highest was C$0.55 in the past 12 months.

What is Microbix Biosystms J’s market cap?

Microbix Biosystms J’s market cap is C$39.91M.

When is Microbix Biosystms J’s upcoming earnings report date?

Microbix Biosystms J’s upcoming earnings report date is Aug 14, 2025 which is tomorrow.

How were Microbix Biosystms J’s earnings last quarter?

Microbix Biosystms J released its earnings results on May 15, 2025. The company reported C$0 earnings per share for the quarter, the consensus estimate of N/A by C$0.

Is Microbix Biosystms J overvalued?

According to Wall Street analysts Microbix Biosystms J’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Microbix Biosystms J pay dividends?

Microbix Biosystms J does not currently pay dividends.

What is Microbix Biosystms J’s EPS estimate?

Microbix Biosystms J’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Microbix Biosystms J have?

Microbix Biosystms J has 140,025,390 shares outstanding.

What happened to Microbix Biosystms J’s price movement after its last earnings report?

Microbix Biosystms J reported an EPS of C$0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went down -5.556%.

Which hedge fund is a major shareholder of Microbix Biosystms J?

Currently, no hedge funds are holding shares in TSE:MBX

Microbix Biosystms Stock Smart Score

Neutral

Fundamentals

Return on Equity

5.32%

Trailing 12-Months

Asset Growth

3.83%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Microbix Biosystms J

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. It manufactures a range of critical biological materials for the diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment and proficiency (QAPs) that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows. The company also applies its biological expertise and infrastructure to develop other proprietary products, primarily viral transport medium (DxTM) to stabilize patient samples for lab-based testing and Kinlytic Urokinase, a biologic thrombolytic drug used to treat blood clots. It sells QAPs to lab accreditation organizations, diagnostics companies, and clinical labs through a network of regional distributors. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.

Microbix Biosystms (MBX) Earnings & Revenues

Historic Earnings Reports

MBX Stock 12 Month Forecast

Average Price Target

C$0.50

▲(78.57% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"C$0","1":"C$1","-1":"-C$1","-0.5":"-C$0.5","0.5":"C$0.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":0.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">C$0.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">C$0.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">C$0.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,-0.5,0,0.5,1],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.3,0.3153846153846154,0.33076923076923076,0.34615384615384615,0.36153846153846153,0.3769230769230769,0.3923076923076923,0.4076923076923077,0.4230769230769231,0.43846153846153846,0.45384615384615384,0.46923076923076923,0.4846153846153846,{"y":0.5,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.3,0.3153846153846154,0.33076923076923076,0.34615384615384615,0.36153846153846153,0.3769230769230769,0.3923076923076923,0.4076923076923077,0.4230769230769231,0.43846153846153846,0.45384615384615384,0.46923076923076923,0.4846153846153846,{"y":0.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.3,0.3153846153846154,0.33076923076923076,0.34615384615384615,0.36153846153846153,0.3769230769230769,0.3923076923076923,0.4076923076923077,0.4230769230769231,0.43846153846153846,0.45384615384615384,0.46923076923076923,0.4846153846153846,{"y":0.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":0.59,"date":1590969600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.39,"date":1704067200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.38,"date":1706745600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.34,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.34,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.3,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.41,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.49,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.44,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.42,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.36,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.33,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.3,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >